Uterocervical Angle in the Termination of Second Trimester Pregnancy
NCT ID: NCT03220607
Last Updated: 2017-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2016-10-15
2017-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Uterocervical Angle in the Pregnancy Termination of Multiparous Women
NCT03400358
The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
NCT06164067
Cervical Length on Pregnancy Termination
NCT04013035
Uterocervical Angle: a Screening Tool That Estimates the Latent Phase Duration in Post Term Pregnancies
NCT04848701
Uterocervical Angle in Patients With Preterm Premature Rupture of the Membranes
NCT04095507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators are aimed to investigate predictive role of both cervical length and UCA in the termination of second trimester pregnancy.The investigators focused on nulliparous women who are taking misoprostol for the cervical preparation and aim to measure their UCA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Medical induced abortion
120 singleton nulliparous patients are planning to complete the study period. Study group constitute of second trimester pregnancies between 14-24 weeks of gestation. All participants were nulliparous and had no systemic illnesses. The uterocervical angle will be measured in all participants before the induction of labor.
uterocervical angle
uterocervical angle is the angle between lower segment of uterus and cervix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterocervical angle
uterocervical angle is the angle between lower segment of uterus and cervix
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no previous systemic illnesses
Exclusion Criteria
* previous cesarean section
* history of dilatation and curettage (D\&C)
* history of LEEP and cervical conization
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Berna Aslan Cetin
MD,ObGYN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alev Atis, MD,ObGyn
Role: STUDY_DIRECTOR
Kanuni Sultan Suleyman Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kanuni SSTRH
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Uterocervical angle: a novel ultrasound screening tool to predict spontaneous preterm birth.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.